Terms: = Gastric cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD AND Clinical Outcome
466 results:
1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.
Sun M; Gu Y; Fang H; Shao F; Lin C; Zhang H; Li H; He H; Li R; Wang J; Liu H; Xu J
Cancer Sci; 2024 Mar; 115(3):905-915. PubMed ID: 38148578
[TBL] [Abstract] [Full Text] [Related]
3. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. Helicobacter pylori virulence genotypes and their relationship with precursor lesions of gastric malignancy and histological parameters in infected patients in Colombia.
Acosta-Astaiza C; López-Sandoval A; Bonilla-Chaves J; Valdes-Valdes A; Romo-Romero W
Rev Peru Med Exp Salud Publica; 2023; 40(3):348-353. PubMed ID: 37991039
[TBL] [Abstract] [Full Text] [Related]
6. Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer.
Hwang N; Yoon BK; Chun KH; Kim H; Lee Y; Kim JW; Jeon H; Kim TH; Kim MY; Fang S; Cheong JH; Kim JW
Exp Mol Med; 2023 Nov; 55(11):2461-2472. PubMed ID: 37919422
[TBL] [Abstract] [Full Text] [Related]
7. Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Xiong JX; Li YT; Tan XY; Chen T; Liu BH; Fu L
Acta Pharmacol Sin; 2024 Feb; 45(2):405-421. PubMed ID: 37814123
[TBL] [Abstract] [Full Text] [Related]
8. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
9. Comparing effectiveness and safety of paclitaxel plus raltitrexed
Zhao X; Chen Z; Zhang X; Zhu X; Zhang W; Qiu L; Wang C; Huang M; Zhang Z; Li W; Yang L; Guo W
Cancer Biol Med; 2023 Aug; 20(9):682-8. PubMed ID: 37653589
[TBL] [Abstract] [Full Text] [Related]
10. PYloroplasty versus No Intervention in gastric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trial.
Okada N; Kinoshita Y; Nishihara S; Kurotaki T; Sato A; Kimura K; Kushiya H; Umemoto K; Furukawa S; Yamabuki T; Takada M; Kato K; Ambo Y; Nakamura F
Trials; 2023 Jun; 24(1):412. PubMed ID: 37337238
[TBL] [Abstract] [Full Text] [Related]
11. Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
Veldhuizen GP; Röcken C; Behrens HM; Cifci D; Muti HS; Yoshikawa T; Arai T; Oshima T; Tan P; Ebert MP; Pearson AT; Calderaro J; Grabsch HI; Kather JN
Gastric Cancer; 2023 Sep; 26(5):708-720. PubMed ID: 37269416
[TBL] [Abstract] [Full Text] [Related]
12. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
[TBL] [Abstract] [Full Text] [Related]
13. Costs and clinical benefits of enhanced recovery after surgery (ERAS) in pancreaticoduodenectomy: an updated systematic review and meta-analysis.
Noba L; Rodgers S; Doi L; Chandler C; Hariharan D; Yip V
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6639-6660. PubMed ID: 36629919
[TBL] [Abstract] [Full Text] [Related]
14. outcomes of feeding jejunostomy after pancreaticoduodenectomy: A single-center experience.
Yamamoto N; Aoyama T; Murakawa M; Kamiya M; Shiozawa M; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S444-S448. PubMed ID: 36511001
[TBL] [Abstract] [Full Text] [Related]
15. Differential Expression of RSK4 Transcript Isoforms in cancer and Its clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract] [Full Text] [Related]
16. The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer.
Sun X; Zhang Z; Wang Z; Xie R; Yi C; Liu H; Chi X; Li T; Liu H; Han Y; Pang X; Cui Y; Liu Z
Front Immunol; 2022; 13():1033967. PubMed ID: 36479101
[TBL] [Abstract] [Full Text] [Related]
17. Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association.
El-Sheikh NM; Abulsoud AI; Wasfey EF; Hamdy NM
Pathol Res Pract; 2022 Dec; 240():154183. PubMed ID: 36327824
[TBL] [Abstract] [Full Text] [Related]
18. Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.
Im S; Cho YK; Kang D; Shin GY; Jung ES; Song KY; Lee SH; Park JM
J Gastroenterol Hepatol; 2022 Dec; 37(12):2255-2263. PubMed ID: 36203318
[TBL] [Abstract] [Full Text] [Related]
19. Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer.
Jiang S; Ding X; Wu Q; Cheng T; Xu M; Huang J
Front Immunol; 2022; 13():980986. PubMed ID: 36032097
[TBL] [Abstract] [Full Text] [Related]
20. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
[Next]